STOCK TITAN

[Form 4] The Charles Schwab Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), reported multiple dispositions of Common Stock on 09/04/2025 executed under a Rule 10b5-1 trading plan adopted on August 14, 2024. The filing shows sales of 14,400 shares (reported at a weighted-average price of $96.6377) and 9,600 shares (weighted-average $96.6372), with the transactions executed in multiple trades at prices ranging from $96.235 to $96.93. Following the reported transactions, the filing discloses beneficial ownership positions including 1,449,256.6599 shares held indirectly by a trust and 450,514 shares held indirectly by a spouse as trustee. The Form 4 was signed by an attorney-in-fact on 09/05/2025.

Carolyn Schwab-Pomerantz, membro del consiglio di The Charles Schwab Corporation (SCHW), ha comunicato multiple cessioni di Azioni Ordinarie il 04/09/2025 eseguite nell'ambito di un piano di trading ai sensi della Rule 10b5-1 adottato il 14 agosto 2024. Il documento riporta la vendita di 14.400 azioni (prezzo medio ponderato $96,6377) e di 9.600 azioni (prezzo medio ponderato $96,6372), con operazioni effettuate in più trade a prezzi compresi tra $96,235 e $96,93. A seguito delle transazioni dichiarate, il filing indica posizioni di proprietà beneficiaria comprendenti 1.449.256,6599 azioni detenute indirettamente da un trust e 450.514 azioni detenute indirettamente dal coniuge in qualità di trustee. Il Modulo 4 è stato firmato per procura il 05/09/2025.

Carolyn Schwab-Pomerantz, directora de The Charles Schwab Corporation (SCHW), informó múltiples enajenaciones de Acciones Comunes el 04/09/2025 ejecutadas bajo un plan de negociación conforme a la Rule 10b5-1 adoptado el 14 de agosto de 2024. La presentación muestra ventas de 14.400 acciones (precio medio ponderado $96,6377) y de 9.600 acciones (precio medio ponderado $96,6372), con transacciones realizadas en múltiples operaciones a precios que oscilaron entre $96,235 y $96,93. Tras las operaciones notificadas, el filing declara posiciones de propiedad beneficiaria que incluyen 1.449.256,6599 acciones mantenidas indirectamente por un fideicomiso y 450.514 acciones mantenidas indirectamente por el cónyuge como fiduciario. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

Carolyn Schwab-Pomerantz는 The Charles Schwab Corporation (SCHW)의 이사로서 2025-09-04에 Rule 10b5-1 거래계획에 따라 여러 건의 보통주 처분을 보고했습니다. 해당 거래계획은 2024년 8월 14일에 채택되었습니다. 신고서에는 14,400주(가중평균가격 $96.6377) 및 9,600주(가중평균 $96.6372) 매각이 기록되어 있으며, 거래는 $96.235에서 $96.93 사이의 가격으로 여러 차례에 걸쳐 실행되었습니다. 보고된 거래 이후에는 신탁이 간접 보유한 1,449,256.6599주와 신탁인으로서 배우자가 간접 보유한 450,514주 등 실질적 소유권 위치가 공개되어 있습니다. Form 4는 2025-09-05에 법정대리인이 서명했습니다.

Carolyn Schwab-Pomerantz, administratrice de The Charles Schwab Corporation (SCHW), a déclaré plusieurs cessions d'actions ordinaires le 04/09/2025 exécutées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 14 août 2024. Le dépôt indique des ventes de 14 400 actions (prix moyen pondéré $96,6377) et de 9 600 actions (prix moyen pondéré $96,6372), les transactions ayant été effectuées en plusieurs opérations à des prix allant de $96,235 à $96,93. À la suite des transactions signalées, le filing révèle des positions de propriété bénéficiaire comprenant 1.449.256,6599 actions détenues indirectement par une fiducie et 450.514 actions détenues indirectement par l'époux(se) en qualité de fiduciaire. Le Formulaire 4 a été signé par un mandataire le 05/09/2025.

Carolyn Schwab-Pomerantz, Direktorin der The Charles Schwab Corporation (SCHW), meldete mehrere Veräußerungen von Stammaktien am 04.09.2025, ausgeführt im Rahmen eines Rule-10b5-1-Handelsplans, der am 14. August 2024 angenommen wurde. Die Einreichung weist Verkäufe von 14.400 Aktien (gewogener Durchschnittspreis $96,6377) und 9.600 Aktien (gewogen $96,6372) aus, wobei die Transaktionen in mehreren Trades zu Preisen zwischen $96,235 und $96,93 ausgeführt wurden. Nach den gemeldeten Transaktionen gibt die Meldung wirtschaftliche Besitzverhältnisse an, darunter 1.449.256,6599 Aktien, die indirekt von einem Trust gehalten werden, und 450.514 Aktien, die indirekt vom Ehegatten als Treuhänder gehalten werden. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Sales executed under a Rule 10b5-1 plan, adopted August 14, 2024, which supports pre-arranged compliance with insider trading rules
  • Detailed execution transparency: weighted-average prices and trade price ranges are disclosed
  • Significant retained ownership is reported (e.g., 1,449,256.6599 shares indirectly by trust and 450,514 indirectly by spouse as trustee)
Negative
  • Dispositions of shares: 14,400 and 9,600 shares were reported sold on 09/04/2025
  • Multiple trades were executed across a price range ($96.235 to $96.93), which may complicate precise per-trade analysis

Insights

TL;DR: Routine insider sales under a 10b5-1 plan; transactions were executed across multiple trades at near-$96.6 prices.

The sales reported are dispositions, not exercises or derivative events, and were executed pursuant to a pre-established Rule 10b5-1 plan adopted in August 2024, which typically indicates pre-planned sales rather than opportunistic trading. The weighted-average prices ($96.6377 and $96.6372) and disclosed price ranges provide transparency on execution. The reporting person retains substantial indirect holdings (over 1.4 million shares by trust and ~450k by spouse as trustee), suggesting continued significant economic interest in SCHW.

TL;DR: Governance practices observed: use of 10b5-1 plan and attorney-in-fact signature; disclosure appears complete for the transactions listed.

The filing identifies the reporting person as a director and indicates the trades were made pursuant to a Rule 10b5-1 plan, which supports compliance with insider trading policies. The filing includes weighted-average prices, price ranges, and the plan adoption date, and it is signed by an authorized attorney-in-fact, meeting common disclosure standards. No amendments or indications of unusual trading mechanics are present in the provided content.

Carolyn Schwab-Pomerantz, membro del consiglio di The Charles Schwab Corporation (SCHW), ha comunicato multiple cessioni di Azioni Ordinarie il 04/09/2025 eseguite nell'ambito di un piano di trading ai sensi della Rule 10b5-1 adottato il 14 agosto 2024. Il documento riporta la vendita di 14.400 azioni (prezzo medio ponderato $96,6377) e di 9.600 azioni (prezzo medio ponderato $96,6372), con operazioni effettuate in più trade a prezzi compresi tra $96,235 e $96,93. A seguito delle transazioni dichiarate, il filing indica posizioni di proprietà beneficiaria comprendenti 1.449.256,6599 azioni detenute indirettamente da un trust e 450.514 azioni detenute indirettamente dal coniuge in qualità di trustee. Il Modulo 4 è stato firmato per procura il 05/09/2025.

Carolyn Schwab-Pomerantz, directora de The Charles Schwab Corporation (SCHW), informó múltiples enajenaciones de Acciones Comunes el 04/09/2025 ejecutadas bajo un plan de negociación conforme a la Rule 10b5-1 adoptado el 14 de agosto de 2024. La presentación muestra ventas de 14.400 acciones (precio medio ponderado $96,6377) y de 9.600 acciones (precio medio ponderado $96,6372), con transacciones realizadas en múltiples operaciones a precios que oscilaron entre $96,235 y $96,93. Tras las operaciones notificadas, el filing declara posiciones de propiedad beneficiaria que incluyen 1.449.256,6599 acciones mantenidas indirectamente por un fideicomiso y 450.514 acciones mantenidas indirectamente por el cónyuge como fiduciario. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

Carolyn Schwab-Pomerantz는 The Charles Schwab Corporation (SCHW)의 이사로서 2025-09-04에 Rule 10b5-1 거래계획에 따라 여러 건의 보통주 처분을 보고했습니다. 해당 거래계획은 2024년 8월 14일에 채택되었습니다. 신고서에는 14,400주(가중평균가격 $96.6377) 및 9,600주(가중평균 $96.6372) 매각이 기록되어 있으며, 거래는 $96.235에서 $96.93 사이의 가격으로 여러 차례에 걸쳐 실행되었습니다. 보고된 거래 이후에는 신탁이 간접 보유한 1,449,256.6599주와 신탁인으로서 배우자가 간접 보유한 450,514주 등 실질적 소유권 위치가 공개되어 있습니다. Form 4는 2025-09-05에 법정대리인이 서명했습니다.

Carolyn Schwab-Pomerantz, administratrice de The Charles Schwab Corporation (SCHW), a déclaré plusieurs cessions d'actions ordinaires le 04/09/2025 exécutées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 14 août 2024. Le dépôt indique des ventes de 14 400 actions (prix moyen pondéré $96,6377) et de 9 600 actions (prix moyen pondéré $96,6372), les transactions ayant été effectuées en plusieurs opérations à des prix allant de $96,235 à $96,93. À la suite des transactions signalées, le filing révèle des positions de propriété bénéficiaire comprenant 1.449.256,6599 actions détenues indirectement par une fiducie et 450.514 actions détenues indirectement par l'époux(se) en qualité de fiduciaire. Le Formulaire 4 a été signé par un mandataire le 05/09/2025.

Carolyn Schwab-Pomerantz, Direktorin der The Charles Schwab Corporation (SCHW), meldete mehrere Veräußerungen von Stammaktien am 04.09.2025, ausgeführt im Rahmen eines Rule-10b5-1-Handelsplans, der am 14. August 2024 angenommen wurde. Die Einreichung weist Verkäufe von 14.400 Aktien (gewogener Durchschnittspreis $96,6377) und 9.600 Aktien (gewogen $96,6372) aus, wobei die Transaktionen in mehreren Trades zu Preisen zwischen $96,235 und $96,93 ausgeführt wurden. Nach den gemeldeten Transaktionen gibt die Meldung wirtschaftliche Besitzverhältnisse an, darunter 1.449.256,6599 Aktien, die indirekt von einem Trust gehalten werden, und 450.514 Aktien, die indirekt vom Ehegatten als Treuhänder gehalten werden. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schwab-Pomerantz Carolyn

(Last) (First) (Middle)
3000 SCHWAB WAY

(Street)
WESTLAKE TX 76262

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SCHWAB CHARLES CORP [ SCHW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/04/2025 S(1) 14,400 D $96.6377(2) 1,449,256.6599 I by Trust
Common Stock 09/04/2025 S(1) 9,600 D $96.6372(3) 450,514 I by Spouse as Trustee
Common Stock 9,624 D
Common Stock 2,798 I by LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.
2. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
/s/ P. Blake Allen, Attorney-in-fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for SCHW on this Form 4?

Carolyn Schwab-Pomerantz reported dispositions of Common Stock on 09/04/2025, including sales of 14,400 and 9,600 shares executed under a 10b5-1 plan.

Were these trades made under a 10b5-1 trading plan for SCHW?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2024.

What prices were the SCHW shares sold at according to the filing?

The filing reports weighted-average prices of $96.6377 and $96.6372, with execution prices ranging from $96.235 to $96.93.

How much SCHW stock does the reporting person still beneficially own?

The Form 4 discloses indirect beneficial holdings including 1,449,256.6599 shares by a trust and 450,514 shares by spouse as trustee following the transactions.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by P. Blake Allen, Attorney-in-fact on 09/05/2025.
Schwab (CHARLES) Corp. (The)

NYSE:SCHW

SCHW Rankings

SCHW Latest News

SCHW Latest SEC Filings

SCHW Stock Data

177.22B
1.70B
6.07%
84.6%
1.1%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
WESTLAKE